Pros and Cons
Lucinda K. Porter goes over what you need to know about the newest hepatitis C drug Sovaldi.
Sovaldi (Sofosbuvir) Approved
FDA approves new Giilead first-in-class once-daily oral nucleotide analog polymerase inhibitor.
Getting a Dopplar Ultrasound?
Karen Hoyt overviews a common hepatitis diagnostic tool your doctor may use to show the size, condition and shape of your liver through treatment
New Options Coming Soon
Keep an eye out for off-label Hepatitis C treatment options without ribavirin and interferon, says Margaret Dudley.
Get through hep C treatment more easily by setting these weekly achievable goals, brought to you by Connie M. Welch.
In phase III trials, Abbvie's new interferon-free regimen plus ribavirin cures 96% of people with hepatitis C.
FDA Approves Olysio
Janssen Therapeutics' Ns3/4A protease inhibitor Olysio (simeprevir) has been approved for the treatment of genotype 1 hep C.
Check out viral hepatitis training resources for health care providers and professionals.
KO-ing Hep C
Preliminary findings suggest that one day in the not-so-near future, the virus may be curable with a single infusion.
Waving the White Flag
AASLD Liver Conference shows the means to blow hepatitis C off the map is just within reach.
In the current issue, Congressman Hank Johnson talks about being cured of his hep C.
Potential Price War
Express Scripts may try to pit drugmakers against each other in 2015 to lower their prices for new hepatitis treatments.
Good Time to Enroll
Users report major improvements to Healthcare.gov, making the insurance sign-up process as quick as 30 minutes.
Pinpointing the Epidemic
Dirty acupuncture practices raise hepatitis C risk for many Asian Americans.
That's What She Said
Check out what everyone's talking about in the Hep Forums.